Wednesday May 12th

05:30 pm

CONGRESS OPENING CEREMONY

06:00 pm

Opening Lecture

Chair: Fruchart J.-C. (France)

Metabolic syndrome ? From new epidemiology to new definition: who is the violin in the quartet ?

Shlyakhto Evgeny (Russia)

Thursday May 13th

Friday May 14th

Saturday May 15th

M

O

R

N

I

N

G

08:30 am / 10:00 am

08:30 am / 10:30 am

09:00 am / 10:30 am

ACADEMIC SESSION I

Metabolic disorders:
global risks, diagnosis and management

Chair: Brewer B. (USA)

Odawara M. (Japan)

Amarenco P. (France)

Ogawa H. (Japan)

R³i Symposium

Lipid-related residual vascular risk.

Opening the new era of vascular prevention

Fruchart J.-C. (France)

Sacks F. (USA)

Hermans M. (Belgium)

Ginsberg H. (USA)

ACADEMIC SESSION V

Metabolic and genetic biomarkers

Chair: Carmena R. (Spain)

Davignon J. (Canada)

Koenig W. (Germany)

Froguel P. (France)

10:00 am / 10:45 am

State of the Art Lecture

Chair: Fruchart J.-C. (France)

Al-Rubeaan K. (Saudi Arabia)

10:45 / 11:15 am

Coffee break

10:30 am / 11:00 am

Coffee break

10:30 am / 11:00 am

Coffee break

11:15 am / 12:45 pm

11:00 am / 12:30 pm

11:00 am / 12:30 pm

Symposium sponsored by
SOLVAY PHARMACEUTICALS 

The unfinished business in
vascular risk reduction

Chair: Fruchart J.-C. (France)

Fruchart J.-C. (France)

Elam M. (USA)

O'Brien R. (Australia)

Bersot T. (USA)

Symposium sponsored by KOWA

Future therapeutic approaches
for atherosclerosis
Potential and application of
novel statin

Chair: Kita T. (Japan)

Matsuzawa Y. (Japan)

Corsini A. (Italy)

Egashira K. (Japan)

ACADEMIC SESSION VI

No traditional risk factors of cardiometabolic disease

Chair: Sadikot S.M. (India)

Ahmed Q. (USA)

Guzik T. (Poland)

Rouis M. (France)

12:45 pm / 02:00 pm

Lunch

12:30 pm / 02:00 pm

Lunch

12:30 pm / 02:00 pm

Lunch

A

F

T

E

R

N

O

O

N

02:00 pm / 03:30 pm

02:00 pm / 03:30 pm

02:00 pm / 03:00 pm

FONDATION CŒUR ET ARTERES

Symposium

Statins and fibrates in CHD prevention:
where are we now ?

Chair: Greten H. (Germany)

Assmann G. (Germany)

Packard C. (UK)

Zambon A. (Italy)

Valensi P. (France)

ACADEMIC SESSION III

Lifestyle and exercise versus medical therapies in prevention and management of the metabolic syndrome

Chair: Sacks F. (USA)

Farinaro E. (Italy)

Kodama T. (Japan)

Carmena R. (Spain)

ORAL COMMUNICATIONS

SELECTED FROM ABSTRACTS

Chair: Rouis M. (France)

03:30 pm / 04:00 pm

Coffee break

03:30 pm / 04:00 pm
Coffee break

03:00 pm / 03:30 pm
Coffee break

04:00 pm / 05:30 pm

04:00 pm / 05:30 pm

03:30 pm / 05:30 pm

ACADEMIC SESSION II

New targets in drug development

Chair: Hermans M. (Belgium)

Krempf M. (France)

Gupta S. (UK)

Duriez P. (France)

ACADEMIC SESSION IV

Metabolic dyslipoproteinemia and atherosclerosis

Chair: Davignon J. (Canada)

Sadikot S. M. (India)

Ceska R. (Czek Republic)

Brewer B. (USA)

POSTER SESSION

Chair: Fruchart J.-C.(France)

END OF THE CONGRESS